- Home
- PLUT vs ESLA Comparison
PLUT vs ESLA Comparison
Compare PLUT & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUT
- ESLA
- Stock Information
- Founded
- PLUT 2018
- ESLA 2021
- Country
- PLUT Hong Kong
- ESLA United States
- Employees
- PLUT N/A
- ESLA N/A
- Industry
- PLUT
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLUT
- ESLA Health Care
- Exchange
- PLUT NYSE
- ESLA Nasdaq
- Market Cap
- PLUT 35.6M
- ESLA 35.5M
- IPO Year
- PLUT 2025
- ESLA N/A
- Fundamental
- Price
- PLUT $2.25
- ESLA $0.99
- Analyst Decision
- PLUT
- ESLA Strong Buy
- Analyst Count
- PLUT 0
- ESLA 1
- Target Price
- PLUT N/A
- ESLA $16.00
- AVG Volume (30 Days)
- PLUT 29.5K
- ESLA 520.0K
- Earning Date
- PLUT 01-01-0001
- ESLA 05-14-2025
- Dividend Yield
- PLUT N/A
- ESLA N/A
- EPS Growth
- PLUT N/A
- ESLA N/A
- EPS
- PLUT N/A
- ESLA N/A
- Revenue
- PLUT $1,435,597.00
- ESLA N/A
- Revenue This Year
- PLUT N/A
- ESLA $101.09
- Revenue Next Year
- PLUT N/A
- ESLA N/A
- P/E Ratio
- PLUT N/A
- ESLA N/A
- Revenue Growth
- PLUT 1.42
- ESLA N/A
- 52 Week Low
- PLUT $2.07
- ESLA $0.63
- 52 Week High
- PLUT $4.22
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- PLUT N/A
- ESLA 50.39
- Support Level
- PLUT N/A
- ESLA $0.94
- Resistance Level
- PLUT N/A
- ESLA $1.02
- Average True Range (ATR)
- PLUT 0.00
- ESLA 0.12
- MACD
- PLUT 0.00
- ESLA -0.01
- Stochastic Oscillator
- PLUT 0.00
- ESLA 52.50
About PLUT PLUTUS FINANCIAL GROUP LIMITED
Plutus Financial Group Ltd provides financial services. It mainly offers (i) securities dealings and brokerage services (ii) margin financing services and (iii) underwriting and placing services.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.